Skip to main content

Lupus

      The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020. Watch now!
      Rheumatology Round-Up with Drs. Kavanaugh & Cush

      The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020.

      Lifestyle and Risk of RA, Lupus: Dr. Janet Pope

      Dr. Janet Pope reviews abstracts #1198 and #1473 presented at the 2020 ACR annual meeting.

      Pregnancy Outcomes in Lupus and SpA: Dr. Kathryn Dao

      Dr. Dao reviews abstracts #1770, #1771 and #1762 presented at the 2020 ACR annual meeting. 

      RT @MeralElRamahiMD: Summary of #ACR20 part B:
      - The future is bright with many trainees producing great research per Dr

      Meral K. El Ramahi, MD MeralElRamahiMD

      4 years 7 months ago
      Summary of #ACR20 part B: - The future is bright with many trainees producing great research per Dr. Diane Karen - Belimumab (phase III) reduced proteinuria, improved renal for, and helped w/ tapering of GC in pts w/ lupus nephritis but more infect in GC group @RheumNow
      RT @ejdein1: #ACR20 imaging competition: 27 yo F with h/o SLE nephritis s/p kidney transplant p/w abdominal pain due to

      Eric Dein ejdein1

      4 years 7 months ago
      #ACR20 imaging competition: 27 yo F with h/o SLE nephritis s/p kidney transplant p/w abdominal pain due to abdominal wall tophus @RheumNow. https://t.co/iDlF3neIYM
      Pregnancy in SLE is a high risk situation and active disease can lead to fetal loss, pre-term birth, IUGR and neonatal lupus syndromes. In a study by Dr. Michelle Petri and colleagues, they evaluated whether the LLDAS at the start of pregnancy was predictive of pregnancy outcome.
      Belimumab in Lupus Nephritis: Dr. Janet Pope

      Dr. Janet Pope reviews abstract #1441 presented at the 2020 ACR annual meeting.

      RT @ACRheum: With Phase 2 of the Accelerating Medicines Partnership study of SLE underway, an #ACR20 session featured a

      American College of Rheumatology ACRheum

      4 years 7 months ago
      With Phase 2 of the Accelerating Medicines Partnership study of SLE underway, an #ACR20 session featured a panel that reviewed the methods being used to generate data & discussed some of the findings. Read the recap → https://t.co/hTnCdfBn10
      Antimalarials and Retinopathy: Dr. Janet Pope

      Dr. Janet Pope reviews abstract #1825 at the 2020 ACR annual meeting.

      RT @Janetbirdope: @uptoTate @RheumNow Agree. MD global is Often SJC taking into consideration activity severity and loca

      Janet Pope Janetbirdope

      4 years 7 months ago
      @uptoTate @RheumNow Agree. MD global is Often SJC taking into consideration activity severity and location of joints. Ex SJC of two ankles or knees is higher MD global than 2 MCPs. All N of SJC are not =. @RheumNow
      RT @DrMiniDey: Very low #vitaminD levels <20ng/mL are associated with renal insufficiency in patients with #SLE.
      Abs

      Mrinalini Dey DrMiniDey

      4 years 7 months ago
      Very low #vitaminD levels <20ng/mL are associated with renal insufficiency in patients with #SLE. Abs#1789 #ACR20 @RheumNow https://t.co/dBm3ZlQOso
      Here are my highlights from day three, Sunday, of the ACR 2020 Convergence. 
      Smartphone T2T management of RA &amp; SLE is possible. With over 127,316 DAS28 &amp; 42,593 SLEDAI assessments over 2 yr

      Dr. John Cush RheumNow

      4 years 7 months ago
      Smartphone T2T management of RA & SLE is possible. With over 127,316 DAS28 & 42,593 SLEDAI assessments over 2 yrs. T2T was lowest in spring for both, correlating w/ holidays in China. #ACR20 Abstr#1018 https://t.co/bGJtSTDqzo https://t.co/34za6kokOp
      ×